The study in Nature Microbiology reviews the concept of immune imprinting and its influence on antibody responses to SARS-CoV-2, highlighting challenges for COVID-19 booster vaccination efficacy against emerging variants. Researchers suggest that understanding immune imprinting is crucial for developing vaccines that elicit broad and lasting immune protection.
Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2023, and Provide Corporate Update – Biotech Investments
Issuer: Immunic, Inc. / Key word(s): Miscellaneous 15.02.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic, Inc. to